Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology
Journal Information
Issue
Vol. 19. Issue S1.
Abstracts of the 2020 Annual meeting of the Mexican Association of Hepatology (AMH) – XV Congreso Nacional de Hepatología (23-25 de julio)
Pages 1-28 (September 2020)
Incidental finding of fatty liver in necropsies
I.E. Bravo-Espinoza, F. Higuera de la Tijera, G. Arist-Urista, M.A. Durán-Padilla, J.L. Pérez-Hernández, R.Y. López-Pérez, P.L. Pérez-Santos, J.L. Montenegro-Tablada, J. Escobedo-Uribe, A. Servín-Caamaño
Ann Hepatol. 2020;19 Supl 1:1
Open access
Obesity and diabetes as a risk factor of chronic disease of the liver in the regional hospital
P. Rodríguez-Villa, J. Brizuela-Santana, A. Jiménez-Partida, M. Jiménez-Partida, S. Ramírez-Flores, Y. Cortés-Aguilar, A. Bravo-Cuellar, R. Franco-Topete, R. Sepúlveda-Castro Rogelio
Ann Hepatol. 2020;19 Supl 1:1-2
Open access
Normal values and diagnostic errors of psychometric tests and critical flicker frequency in vulnerable Mexican population
F. Quiroz Compeán, N. Chávez Tapia, S. Ornelas Arroyo, K. Rojas Hernández
Ann Hepatol. 2020;19 Supl 1:2
Open access
Main clinical characteristics of hospitalized cirrhotic patients with acute on chronic liver failure
C.I. Díaz-Valencia, F.A. Lajud-Barquin, M.F. Higuera de la Tijera, J.L. Pérez-Hernández
Ann Hepatol. 2020;19 Supl 1:2
Open access
The fructose enhances the HCC progression in mice under a high intake of fructose in dieT
L. Chávez-Rodríguez, A. Simoni-Nieves, A. Escobedo-Calvario, M. Gerardo-Ramírez, S. Salas-Silva, R. Miranda-Labra, V. Souza, L. Bucio, M.C. Gutiérrez-Ruiz, L.E. Gomez-Quiroz
Ann Hepatol. 2020;19 Supl 1:3
Open access
Gallbladder adenomyomatosis
J. Aquino-Matus, M. Enriquez-Pineda, A. Pereira-Garcia, S. Ornelas-Arroyo
Ann Hepatol. 2020;19 Supl 1:3
Open access
HGF induces a protective response in a preclinical model of nephropathy induced by acute cholestasis
J. Lopez-Ramirez, E.S. Salas-Silva, J. Barrera-Chimal, A. Simoni-Nieves, M.C. Gutiérrez-Ruiz, V. Souza, R.U. Miranda-Labra, L.E. Gómez-Quiroz, L. Bucio-Ortiz
Ann Hepatol. 2020;19 Supl 1:3-4
Open access
Prevalence of acute kidney injury in hospitalized patients with cirrhosis and their transition to chronic kidney disease
V. Rodríguez-Granados, I.D. Aranda-Sánchez, G.L. Ojeda-Aguilar, C.M. Del Real-Calzada
Ann Hepatol. 2020;19 Supl 1:4
Open access
Correlation of serum ferritin concentrations with laboratory and demographic paramters and its alteraration by different clinical conditions in patients with liver disease
R. Tijerina-Márquez, O.H. Mendoza-Hernández, E. Cienfuegos-Pecina, J.A. De la Torre-Hernández, G.R. Govea-Torres, L. Muñoz-Espinosa, P. Cordero-Pérez
Ann Hepatol. 2020;19 Supl 1:4-5
Open access
Moringa oleífera decreases insulin resistance, novo lipogenesis and modifies the expression of mirnas in a non-alcoholic esteatohepatitis model
A. Monraz-Méndez, R. Escutia-Gutiérrez, S. Rodríguez-Sanabria, L. Sánchez-Orozco, J. Armendáriz-Borunda, A. Sandoval-Rodríguez
Ann Hepatol. 2020;19 Supl 1:5
Open access
Prolonged-release pirfenidone decreases hepatic miRNAs expression in a NAFLD/NASH experimental model
R. Escutia-Gutiérrez, J.S. Rodríguez-Sanabria, C.A. Monraz-Méndez, A. Santos-García, J. Armendáriz-Borunda, A. Sandoval-Rodríguez
Ann Hepatol. 2020;19 Supl 1:5-6
Open access
Clinical and epidemiological characteristics of patients with autoimmune hepatitis in a center of Northeast Mexico
A.L. Kuljacha-Gastélum, P.A. López-Hernández, M.A. Cornejo-Gutiérrez, V.E. del Toro-Ortiz
Ann Hepatol. 2020;19 Supl 1:6
Open access
Pirfenidone induces epigenetic changes modulating the activity of the ppargamma-SIRT1-DNMT1 axis in hepatic stellate cells
H.C. Monroy-Ramírez, M. Galicia-Moreno, A. Santos-García, J.S. Armendáriz-Borunda
Ann Hepatol. 2020;19 Supl 1:6-7
Open access
Molecular, histological and biochemical changes in a NASH murine model whit a diet high in fats and sugars
J.S. Rodríguez Sanabria, J. García Bañuelos, R. Escutia Gutiérrez, C.A. Monraz Méndez, J. Armendáriz Borunda, A.S. Sandoval Rodríguez
Ann Hepatol. 2020;19 Supl 1:7
Open access
Development of a defatting strategy to reduce lipid accumulation and improve the viability of steatotic grafts in liver transplantation
A. Casillas-Ramírez, A.Y. Rocha-Sánchez, Y.E. Hernández-Olvera, K.Y. Balderas-Osorio, H.Y. Martínez-Padrón, C.A. Barrón-Vargas, P. Cordero-Pérez, H.A. Zapata-Chavira
Ann Hepatol. 2020;19 Supl 1:7-8
Open access
Hepatoprotective effect of sodium (S)-2-hydroxyglutarate against ischemia-reperfusion injury in Wistar rats
E. Cienfuegos-Pecina, D.P. Moreno-Peña, L. Torres-González, D. Garza-Villarreal, O.H. Mendoza-Hernández, R.A. Flores-Cantú, B.A. Samaniego-Sáenz, L.E. Muñoz-Espinosa, P. Cordero-Pérez
Ann Hepatol. 2020;19 Supl 1:8
Open access
Cellular and molecular characterization of the pirfenidone effects on an hepatocarcinogésis experimental model
J.A. Silva-Gómez, H.C. Monroy-Ramírez, M. Galicia-Moreno, A. Santos-García, J. Armendáriz-Borunda
Ann Hepatol. 2020;19 Supl 1:8-9
Open access
Analysis of the molecular interaction of pirfenidone with PPAR-gamma and effects on the beta-catenine pathway in HEPG2 line
H.C. Monroy-Ramírez, J.A. Silva-Gómez, M. Galicia-Moreno, A. Santos-García, J. Armendáriz-Borunda
Ann Hepatol. 2020;19 Supl 1:9
Open access
Prolonged-release pirfenidone prevents myocardial fibrosis in a mouse nonalcoholic steatohepatitis model
J. Gutiérrez-Cuevas, A. Sandoval-Rodríguez, C. Monroy-Ramírez, A. Santos-García, J. Armendáriz-Borunda
Ann Hepatol. 2020;19 Supl 1:9
Open access
Hepatoprotective effect of nifedipine against ischemia-reperfusion injury in rats
A. Villarreal-Benítez, P. Cordero-Pérez, N.F. Cruz-Urista, E. Cienfuegos-Pecina, D. Villarreal-Garza, D.P. Moreno-Peña, L. Muñoz-Espinosa, L.C. Treviño-Lozano, L. Torres-González
Ann Hepatol. 2020;19 Supl 1:10
Open access
Reported resistance to different antibiotics in cirrhotic patients with spontaneous bacterial peritonitis
T.F. Meléndez Alvarado, F. Higuera de la Tijera, A. Servín Caamaño
Ann Hepatol. 2020;19 Supl 1:10-1
Open access
Sustained viral response in patients with hepatitis C and chronic kidney disease in hemodialysis and treatment with direct acting antivirals in the UMAE 71
E.A. Jasso-Baltazar, F.A. Solís-Galindo, M.A. Muñoz-Hernández
Ann Hepatol. 2020;19 Supl 1:11
Open access
Total cholesterol/high-density lipoprotein cholesterol ratio, high-density lipoprotein triglycerides/colesterol with hepatic fat infiltration grade in non-alcoholic fat liver
C.N. Asencio-Barrientos, E. Torres López, M.I.S. Mejía-Loza, L.C. Barrios-Lupitou, N. Pérez y López, E. García Ruíz, J.A. González-Angulo, E.I. Juárez-Valdés, J.I. Hernández-Solís, H.W. Citalan-Poroj, J. Moreira-Alcivar
Ann Hepatol. 2020;19 Supl 1:11-2
Open access
Incidence and impact of bacterial infection on the forecast of patients with acute liver failure on chronic “ACLF”, hospital juárez de México
J. Moreira-Alcívar, M. Mejía-Loza, C. Asencio-Barrientos, H. Citalan-Poroj, J. Hernández-Solís
Ann Hepatol. 2020;19 Supl 1:12
Open access
“CLIF-C ACLF mortality predictive utility in patients with acute liver failure in chronic “ACLF” in the hospital Juarez de Mexico population
J. Moreira-Alcívar, M. Mejía-Loza, C. Asencio-Barrientos, H. Citalan-Poroj, J. Hernández-Solís
Ann Hepatol. 2020;19 Supl 1:12-3
Open access
The clinical expression of lysosomal acid lipase severity in patients with cryptogenic cirrhosis
A. Solano-Urrusquieta, E. Cerda-Reyes, N. Álvarez-Licona, J. Morales-González, R. Fierros-Oceguera
Ann Hepatol. 2020;19 Supl 1:13
Open access
Hepatocelullar carcinoma is a major risk factor for the development of portal ven thrombosis in cirrhotic patients
C.A. Espinoza, F. Higuera de la Tijera, J.A. Meléndez-Andrade, A. Servín-Caamaño
Ann Hepatol. 2020;19 Supl 1:13-4
Open access
Prevalence and characteristics of cirrhotic patients with portal vein thrombosis admited in the Gastroenterology Department of the Hospital General de Mexico
C.A. Campoverde-Espinoza, F. Higuera de la Tijera, J.A. Meléndez-Andrade, A. Servín-Caamaño
Ann Hepatol. 2020;19 Supl 1:14
Open access
Prevalence and characteristics of non-cirrhotic patients with thrombosis of the portal system
C.A. Campoverde-Espinoza, F. Higuera de la Tijera, J.A. Meléndez-Andrade, A. Servín-Caamaño
Ann Hepatol. 2020;19 Supl 1:14-5
Open access
Characteristics of ascitic fluid and flow of the portal system in cirrotic patients with diagnosis of portal vein thrombosis
C.A. Campoverde-Espinoza, F. Higuera de la Tijera, J.A. Meléndez-Andrade, A. Servín-Caamaño
Ann Hepatol. 2020;19 Supl 1:15
Open access
Most commonly liver function test alterations on adult patients with septic shock
F. Belmonte-Garcia, A.L. Osorio-Nuñez, M.S. Gonzalez-Hueso
Ann Hepatol. 2020;19 Supl 1:15
Open access
Mexican experience with direct-acting antivirals in the treatment of hepatitis C
J.L. Pérez Hernández, C.A. Arce Salinas, R. Lehmman Mendoza, A. Torre Delgadillo, G. Castro Narro, E. Cerda Reyes, M.V. Ramos Gómez, L. Juárez Chávez, M. Dehesa Violante, L. Muñoz Espinosa, L. Cisneros Garza, I. Aiza Haddad, J.A. Velarde Ruiz Velasco, R. Contreras Omaña, N. García Casarreal, J.A. Carmona Castañeda, M.F. Higuera de la Tijera
Ann Hepatol. 2020;19 Supl 1:16
Open access
Characterization of patients with primary sclerosing cholangitis in a third level hospital
V. López Ladrón de Guevara, C. Alonzo García, A. Vélez Carrión, F. Thomas Lora, B. Astudillo Romero, E. Márquez Guillén, C. Moctezuma Velázquez, N.C. Flores García, G. Castro Narro, A. Torre Delgadillo
Ann Hepatol. 2020;19 Supl 1:16
Open access
Clinical, demographic, radiological and histological features of a series of liver adenomas in a reference hospital
F.C. Thomas Lora, A. Torre Delgadillo, C. Moctezuma Velázquez
Ann Hepatol. 2020;19 Supl 1:16-7
Open access
Characteristics of the overlap syndrome (HAI / CBP, HAI / CEP): a cohort type study in a reference center in Mexico during the period 2008–2018
A. Vélez Carrión, C. Moctezuma Velázquez, A. Torre Delgadillo
Ann Hepatol. 2020;19 Supl 1:17
Open access
Correlation between the index platelet/ spleen diameter with the presence of esophageal varices by endoscopy in cirrhotic patients from the State of Mexico
A.M. Ganado-Escobar, J.A. Moreno-Tapia, M.S. Gonzalez-Huezo, A.L. Osorio-Núñez
Ann Hepatol. 2020;19 Supl 1:17
Open access
Spontaneous bacterial peritonitis and bacterioascitis. Microbiological and resistance profile in a third level hospital
A.M. Ganado-Escobar, X. García-León, D.R. Menéndez-Morales, R.M. Miranda-Cordero, M.S. González-Huezo
Ann Hepatol. 2020;19 Supl 1:18
Open access
Frequency and characteristics of alterations in liver function tests (LFT) in adult patients with COVID-19 (preliminary report)
D. Menéndez-Morales, G.A. Peña-Arellano, M.S. González-Huezo
Ann Hepatol. 2020;19 Supl 1:18
Open access
Evaluación de marcadores fibroticos en células estelares expuestas al extracto metanolico de Turnera diffusa
D.R. Rodriguez-Rodriguez, S. Lozano-Sepúlveda, N. Waskman-De Torres, P. Cordero-Pérez, A.M. Rivas-Estilla
Ann Hepatol. 2020;19 Supl 1:18-9
Open access
Prevalence of spontaneous bacterial peritonitis in patients with hepatic cirrhosis in the military central hospital
E. Perez-Méndez, C. Montejo-Velázquez, J.G. Gándara-Calderón, C. Pantaleón-Martínez, N.C. Fernandez Martínez, M.R. Herrero-Maceda, A. Gutierrez-Atemis, P.D. Flores-Rangel, M.E. Robles-Villagómez, A. Cotino-Guerrero, N.A. Bolaños-Gómez, E. Cerda-Reyes
Ann Hepatol. 2020;19 Supl 1:19
Open access
Comparison of two ROC curve-based methods for determining the cross-point critting frequency in the diagnosis of EHM
A. Villaseñor-Todd, F.J. Bosques-Padilla, E. López-Soriano, C.A. Cortez-Hernandez, J.A. Hernández-Hernández, C. López-Sanchez
Ann Hepatol. 2020;19 Supl 1:19-20
Open access
Impact of liver enzymes on SARSCoV-2 infection and on the severity of clinical disease
A. Servín-Caamaño, D. Reyes-Herrera, A. Flores-López, E.J.A. Robiou-Vivero, F. Martínez-Rivera, V. Galindo-Hernández, C. Casillas-Suárez, O. Chapa-Azuela, A. Chávez-Morales, V.H. Rosales-Salyano, B. Jiménez-Bobadilla, M.L. Hernández-Medel, B. Orozco-Zúñiga, J.R. Zacarías-Ezzat, S. Camacho-Hernández, J.L. Pérez-Hernández, F. Higuera de la Tijera
Ann Hepatol. 2020;19 Supl 1:20
Open access
Development of the analytical method for the quantification of 3-nitrotirosin and 3-chlorothyrosin in human plasma as potential biomarkers to evaluate minimal liver encephalopathy (MHE)
A. Villaseñor Todd, J.A. Hernández-Hernández, R.C. López-Sanchez, F.J. Bosques-Padilla, C.A. Cortez-Hernandez, E. Lopez Soriano
Ann Hepatol. 2020;19 Supl 1:21
Open access
Experience of Yttrium-90 radioembolization in patients with hepatocellular carcinoma
B. Zapote Hernández, S. Amezquita Pérez, J.M. Torres Montoya, I. Verduzco Flores, E. Santiago González, V. Fonseca Morales, A. Gutiérrez Atemis, C. Pantaleón Martínez, N.C. Fernández Martínez, M.R. Herrero Maceda, J.G. Gándara Calderón, E. Cerda Reyes
Ann Hepatol. 2020;19 Supl 1:21-2
Open access
Aspartate aminotransferase as predictor of severity in SARSCoV-2 infection: linear regression model
A. Servín-Caamaño, D. Reyes-Herrera, A. Flores-López, E.J.A. Robiou-Vivero, F. Martínez-Rivera, V. Galindo-Hernández, C. Casillas-Suárez, O. Chapa-Azuela, A. Chávez-Morales, V.H. Rosales-Salyano, B. Jiménez-Bobadilla, M.L. Hernández-Medel, B. Orozco-Zúñiga, J.R. Zacarías-Ezzat, S. Camacho-Hernández, J.L. Pérez-Hernández, F. Higuera-de la Tijera
Ann Hepatol. 2020;19 Supl 1:22
Open access
Classification of alcohol consumption pattern in the Mexican population
M. Martínez-Castillo, D. Rosique-Oramas, Z. Medina Ávila, G. Gutiérrez-Reyes
Ann Hepatol. 2020;19 Supl 1:22-3
Open access
Cell death in patients with different alcohol consumption and alcoholic liver disease
M. Martínez-Castillo, Z. Medina-Avila, D. Rosique-Oramas, E.A. Alamo-Capula, Z.J. Flores-Ambrosio, A. Flores-Torres, M. Galicia-Moreno, Y. Bejar, F. Higuera-De la Tijera, J.L. Pérez-Hernández, D. Kershenobich, G. Gutiérrez-Reyes
Ann Hepatol. 2020;19 Supl 1:23
Open access
Evaluation of TLR-4 in peripheral M1 monocytes and IL-6 and CXCL-8 in alcoholic liver disease
M. Martínez-Castillo, D. Rosique-Oramas, Z. Medina Ávila, F. Parangeo, A. Hernández-Barragán, A. Flores-Torres, J.L. Pérez-Hernández, F. Higuera-De la Tijera, G. Gutiérrez-Reyes
Ann Hepatol. 2020;19 Supl 1:24
Open access
Evaluation of IL-1RA, IL-1β IFN-γ and CXCL-10 as mediators of damage and hepatic repair in chronic hepatitis and fibrosis progresion
A. Hernández-Barragán, J. Limón-Castillo, M. Martínez-Castillo, D. Rosique-Oramas, J.L. Pérez-Hernández, F. Higuera-De la Tijera, P. Cordero-Pérez, L. Muñoz-Espinosa, D. Kershenobich, G. Gutiérrez-Reyes
Ann Hepatol. 2020;19 Supl 1:24
Open access
Effect of pangenotype treatment on chronic hepatitis C. Real life studio
I. Santana Salgado, A. Bautista-Santos, R. Moreno Alcántar
Ann Hepatol. 2020;19 Supl 1:25
Open access
Experience in treatment with direct action antivirals in patients with HCV-HIV coinfection
N. Martínez Gómez, A. Bautista-Santos, R. Moreno Alcántar
Ann Hepatol. 2020;19 Supl 1:25
Open access
Hepatic and gastrointestinal manifestations of SARS-COV-2 infection (COVID-19)
J. Aquino-Matus, I. Lopez-Mendez, E. Juarez-Hernandez, S. Murua-Beltran Gall, J.D. Prieto-Nava, P. Castañeda-Mendez, G. Castro-Narro, M. Uribe
Ann Hepatol. 2020;19 Supl 1:25-6
Open access
Effect of chronic alcohol intake in a pre-clinical model with cholesterol overload
J.M. Alonso-Mora, J.G. Rosales-García, L.E. Gómez-Quiroz, R. Miranda-Labra, V. Souza-Arroyo, L. Bucio-Ortíz, P. Muriel-De la Torre, M.C. Gutiérrez-Ruíz
Ann Hepatol. 2020;19 Supl 1:26
Open access
Acute liver injury and survival in patients with SARS-Cov-2 from the Hospital Central Militar
A. Figueroa-Peña, N.A. Gómez-Bolaños, C. Monejo-Velázquez, E. Muñoz-Monroy, M. Santiago-Torres, S. Hernández-Díaz, María del Rosario Herrero-Maceda, J.G. Gándara-Calderón, J. Torres-Vázquez, E. Cerda-Reyes, M.U. Vázquez-Medina
Ann Hepatol. 2020;19 Supl 1:26-7
Open access
Evaluation of cyclooxigenase inhibitors in hepatic isquemia-reperfusion injury in Wistar rats
A.G. Garza, D.P. Moreno-Peña, D.R. Rodríguez-Rodríguéz, L. Torres-González, L.E. Muñoz-Espinosa, G.R. Govea-Torres, A.N. Garza-Cisneros, E. Cienfuegos-Pecina, P. Cordero-Pérez
Ann Hepatol. 2020;19 Supl 1:27
Open access
Evaluation of atherosclerotic risk in patients with chronic hepatitis C infection
J.G. Solís, E.S. Enciso-López, A. Bautista-Santos, J.C. Anda-Garay, R. Moreno-Alcantar, L. Montiel-López
Ann Hepatol. 2020;19 Supl 1:27-8
Open access
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos